Hosam I. Taha

Hosam I. Taha

Auto-generated profile, based on publicly available information

Hosam I. Taha

Faculty of Medicine Tanta University Tanta Egypt

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
MEMohamed S. Elgendy
Mohamed S. Elgendy
IRIslam Rajab
Islam Rajab
QNQasi Najah
Qasi Najah
MFMohamed A. Faheem
Mohamed A. Faheem
OEOmar K. Elsawy
Omar K. Elsawy
WBWalid Baddoura
Walid Baddoura
Purpose: Recent evidence supports linaclotide (Lin) for colonoscopy preparation. This network meta-analysis evaluates the combination of different pill numbers of Lin with polyethylene glycol (PEG) (high and low volumes in liters (L)) for bowel cleansing. Methods: This systematic review and frequentist network meta-analysis, conducted in October 2024, assessed randomized controlled trials (RCTs) from Scopus, PubMed, Cochrane, WOS, and Embase. Risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI) were calculated for categorical and continuous outcomes. PROSPERO ID: CRD42024618272. Results: Fourteen RCTs with 4,764 participants showed that total Boston Bowel Preparation Scale improved significantly with 2L PEG + 2Lin (MD = 2.03, 95%CI: [0.30:3.76], P = 0.0217), 3L-PEG + 3Lin (MD = 1.30, 95%CI: [0.42:2.18], P = 0.0038), and 4L-PEG (MD = 1.11, 95%CI: 0.23–1.98, P = 0.0129). Adenoma detection was highest with 3L-PEG + 3Lin (RR = 1.60, 95%CI: [1.05:2.43], P = 0.0280), while polyp detection improved with 2L PEG + 3Lin (RR = 1.72, 95%CI: [1.13:2.62], P = 0.0114) and 3L-PEG + 3Lin (RR = 1.33, 95%CI: [1.00:1.77], P = 0.0505). Procedure times were significantly reduced with 3L-PEG + 3Lin (MD = -4.6, 95%CI: [-6.24:-3.24], P < 0.0001), 3L-PEG + 1Lin (P = 0.035), and 4L-PEG (P < 0.01). Abdominal pain and abdominal bloating decreased with 2L PEG + 1Lin (P < 0.01) and 2L PEG + 2Lin (P = 0.021) but increased with 4L-PEG (P = 0.0178). Conclusions: Combining PEG with Lin improves bowel cleanliness compared to 3L-PEG, with 2L PEG + 2Lin being the most effective and well-tolerated. Despite some heterogeneity, the findings suggest that adding Lin may enhance bowel preparation with comparable safety, warranting consideration of individual patient factors.

4 September 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
HTHosam I. Taha
Hosam I. Taha
MEMohamed S. Elgendy
Mohamed S. Elgendy
MEMohamed R. Ezz
Mohamed R. Ezz
KTKhalid Tolba
Khalid Tolba
MSMahmoud El Safty
Mahmoud El Safty
EAEbraheem Albazee
Ebraheem Albazee

12 May 2025 in Coronary Artery Disease
Verified
Journal Article
Closed access
HTHosam I. Taha
Hosam I. Taha
MEMohamed S. Elgendy
Mohamed S. Elgendy
ASAbdalhakim Shubietah
Abdalhakim Shubietah
AAAhmed Mazen Amin
Ahmed Mazen Amin
MEMohamed R. Ezz
Mohamed R. Ezz
IEIslam Y. Elgendy
Islam Y. Elgendy
Intravascular ultrasound (IVUS) or optical frequency domain imaging (OFDI) for guiding percutaneous coronary interventions (PCI) reduces the risk of adverse events compared with angiographic guidance. However, only a few trials compared both modalities. This study aims to assess and compare OFDI- vs. IVUS-guided PCI. We conducted a meta-analysis of randomized controlled trials (RCTs) retrieved from PubMed, Scopus, WOS, Embase, and Cochrane Library till September 2024. The primary outcome was major adverse cardiac events (MACE). Risk ratios (RR) were applied for dichotomous outcomes and mean differences (MD) for continuous outcomes, both with 95% confidence intervals (CI). PROSPERO ID: CRD42024595477. Four RCTs with 1135 patients were included. There was no significant difference between the two modalities in terms of MACE [RR: 0.99; 95% CI: (0.53, 1.86); P = 0.98], all-cause mortality [RR: 0.72; 95% CI: (0.15, 3.56); P = 0.69], cardiac mortality [RR: 1.00; 95% CI: (0.18, 5.68); P = 1.00] and myocardial infarction [RR: 1.21; 95% CI: (0.35, 4.18); P = 0.76]. Additionally, there was no significant difference in PCI success [RR: 1.00; 95% CI: (0.99, 1.02); P = 0.64]. However, OFDI was associated with a significant increase in contrast volume [MD: 19.81 ml; 95% CI: (2.53, 37.09); P = 0.02] and reduction in fluoroscopy time [MD: −7.05 min; 95% CI: (−9.32, −4.79); P < 0.01]. This meta-analysis of RCTs suggests that OFDI is comparable to IVUS in efficacy and safety for guiding PCI, with no significant differences in clinical outcomes. These findings support the use of either modality for PCI guidance. However, additional large-scale, multicenter RCTs to recommended to validate these findings and enhance their generalizability.

2 June 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
RGRamy Ghaly
Ramy Ghaly
AAAhmed Mazen Amin
Ahmed Mazen Amin
SKSamuel Kim
Samuel Kim
HTHosam I. Taha
Hosam I. Taha
MEMohamed S. Elgendy
Mohamed S. Elgendy
MKMirza Khan
Mirza Khan

14 September 2025 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
ASAbdalhakim R. M. Shubietah
Abdalhakim R. M. Shubietah
AAAmeer Awashra
Ameer Awashra
FMFathi Milhem
Fathi Milhem
MAMohammed AbuBaha
Mohammed AbuBaha
MTMaisam Tobeh
Maisam Tobeh
IRIslam Rajab
Islam Rajab

18 July 2025 in JGH Open
Verified
Journal Article
Open access
MAMohamed Abuelazm
Mohamed Abuelazm
AFAhmed Fares
Ahmed Fares
MAMohammad Adam
Mohammad Adam
YSYazan Sallam
Yazan Sallam
AAAhmed Mazen Amin
Ahmed Mazen Amin
FJFouad Jaber
Fouad Jaber
Background & Objective: Few trials have compared the efficacy of intravenous (IV) iron repletion to oral repletion for patients with gastrointestinal bleeding (GIB). We aim to guide clinical decision‐making and optimize treatment strategies through the findings from these studies to provide a step closer to a consensus on the most effective approach to iron supplementation for patients with GIB.Methods: A systematic review and meta‐analysis synthesizing evidence from randomized controlled trials (RCTs) obtained from PubMed, Embase, CENTRAL, Scopus, and Web of Science from inception to April 2024. We used the fixed‐effects model to report dichotomous outcomes using risk ratio (RR) and continuous outcomes using mean difference (MD), with a 95% confidence interval (CI). PROSPERO ID: CRD42024542759.Results: Three RCTs that included 254 patients were included. IV iron was significantly associated with increased complete response (RR: 1.60 with 95% CI [1.24, 2.07], p < 0.01) compared to oral iron, with no significant difference between IV iron and oral iron in partial response (RR: 2.13 with 95% CI [0.60, 7.50], p = 0.24). IV iron was significantly associated with increased Hb concentration (MD: 1.45 g/dL with 95% CI [0.50, 2.40], p < 0.01) and ferritin change (MD: 220.02 μg/L with 95% CI [22.31, 417.73], p = 0.03) compared to oral iron. However, there was no significant difference between IV and oral iron in transferrin saturation (MD: 4.71% with 95% CI [−5.96, 15.38], p = 0.39).Conclusion: With uncertain evidence, IV iron demonstrated increased hemoglobin and ferritin concentrations and achieved complete response rates in patients with GIB.